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Objectives: To elucidate the incidence of significant vein graft stenosis in patients who have undergone bilateral 
i~rainguinal vein grafts. 
Materials: Between 1987 and 1996, 22 patients were identified from our vascular studies database as having undergone 
bilateral infrainguinal vein bypass grafting. 
Methods: Data was obtained from the vascular studies database and by case note review. All patients had been part of 
a vein graft surveillance programme. 
Results: Of the 22 patients with bilateral vein grafts, eight were excluded from further analysis because one or more of 
their grafts failed within 30 postoperative days. In the remaining 14 patients (28 vein grafts) there were 15 primary vein 
graft stenoses. Six patients (43%) had bilateral vein graft stenoses, which is significantly higher (p = 0.0008) than the 
predicted value of 9%, for developing bilateral vein graft stenoses. For those patients who developed a vein graft stenosis 
in their first grafted limb (9/14), 67% (6/14) subsequently developed a vein graft stenosis in their second grafted limb. 
Conclusion: Patients who develop vein graft stenosis in one limb are at a greater isk of developing a contralateraI vein 
graft stenosis if that limb is grafted. This may well be due to individual vein morphology or unidentified systemic factors 
that play a role in the aetiology of vein graft stenosis. 
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Introduction 
For infrainguinal bypass grafts the conduit of choice 
is autologous vein. 1'2 Vein graft failure occurring within 
the first 30 postoperative days can be attributed to 
technical errors incurred at the time of operation. 
However, up to 30% of grafts will develop asignificant 
vein graft stenosis between the first and twelfth 
months, the aetiology of which is intimal hyperplasia 
in the majority of cases. 3-5 The cause of intimal hyper- 
plasia appears to be multifactorial, with both local and 
systemic factors playing a role. Vein morphology has 
been suggested by some authors as being an important 
predetermining factor in the development of vein graft 
stenosis, 68 whilst other groups have disputed this 
claim 9 and several studies have shown that elevated 
systemic factors uch as fibrinogen, 1°-~2 homocysteine, 13'14 
increased lipoprotein(a) ~5 and continued smoking 1°'15 
are associated with an increased risk of developing 
vein graft stenosis. 
* Please address all correspondence to: M. J. McCarthy, Department 
of Surgery, Clinical Science Building, University ofLeicester, Leices- 
ter, U.K. LE2 7LX. 
If systemic factors and vein morphology play a role 
in the development of vein graft stenosis, then it can 
be hypothesised that patients who develop avein graft 
stenosis in one grafted limb would be at a higher isk 
of developing a vein graft stenosis in the contralateral 
limb if it was subsequently vein-grafted. In other 
words, there would be a higher than expected number 
of patients who develop bilateral vein graft stenoses 
than one would predict if the development of vein graft 
stenosis in either limb was completely independent. As
far as we can tell there have been no previously 
reported series, in the medical iterature, on the in- 
cidence of vein graft stenosis in patients who have 
undergone bilateral infrainguinal vein grafts. 
To test this hypothesis we undertook a retrospective 
study of all patients who had undergone bilateral 
infrainguinal vein grafts, for lower limb ischaemia, in 
our unit, over a 9-year period. 
Materials and Methods 
Between 1987 and 1996 there were a total of 326 
infrainguinal vein grafts performed at our unit and, 
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of these, bilateral infrainguinal vein grafts were per- 
formed on 22 patients. A review was undertaken on 
all patients to study graft outcome and to identify the 
development of significant vein graft stenoses that 
required intervention during a period of routine post- 
operative vein graft surveillance. All patients whose 
graft had failed within the first 30 postoperative days 
were excluded from any further analysis with regard 
to the development of significant graft stenoses, as it 
is recognised that graft failure during this time period 
is either due to technical errors incurred at the time 
of grafting or poor vein quality. 
Col.our-coded uplex scans of the grafts took place 
at 1 month after the initial operation and thereafter at 
3-mo~qthly intervals. Al l  scans looked at graft inflow, 
outflow and the proximal and distal anastomoses. A 
peak systolic velocity ratio of >2 was taken to represent 
a significant stenosis and the initial treatment of sten- 
oses was percutaneous transluminal angioplasty 
(PTA). Each patient was assessed for independent risk 
factors, e.g. diabetes mellitus, smoking, hypertension 
and ischaemic heart disease. 
During the same study period, of the 326 infra- 
inguinal vein grafts performed, 98 (30%) developed 
significant primary vein graft stenoses. The incidence 
of vein graft stenosis in our total patient population 
corresponds with previously published data on the 
incidence of vein graft stenosis in infrainguinal vein 
grafts. 4
Statistical analysis 
For vein graft stenoses, the differences between the 
observed and expected findings were analysed using 
the binomial probability test. 
Results 
Twenty-two patients with 44 infrainguinal vein grafts 
were identified. There were 15 males and seven fe- 
males, with a median age of 63 years (51-74) and 67 
years (51-81), respectively. Thirty per cent (13) of lower 
limb vein grafts were for life-limiting intermittent 
claudication of less than 50 m and 70% (31) were for 
critical lower limb ischaemia (which was comprised 
of rest pain, ulceration and/or gangrene). The mean 
follow-up time for each grafted limb was 57 months 
and the median time interval between both limbs being 
grafted was 18 months (2 weeks-108 months). The 
Table 1. Site of distal anastomosis and type of conduit used for 
the 44 infrainguinal vein grafts studied (22 patients) including 
the 16 grafts (eight patients) that were excluded from further 
analysis due to one or more failed grafts within 30 post operative 
days. 
Site of distal Conduit used Grafts Grafts 
anastomosis included excluded 
in study from study 
Tibial vessels ISLSV 9 5 
Composite Reverse 1 1 
pain 
Reverse LSV 4 0 
Above knee ISLSV 2 2 
popliteal artery 
Reverse LSV 0 2 
Below knee ISLSV 9 5 
popliteal rtery 
Reverse LSV 3 1 
ISLSV=h, situ long saphenous vein, LSV=long saphenous vein. 
Table 2. Number of vein graft stenoses occurring in both limbs 
of 14 patients. 
First grafted limb 
Vein graft No stenosis Total 
stenosis 
Second Vein graft 6 0 6 
stenosis 
Grafted No stenosis 3 5 8 
limb 
Total 9 5 14 
type of procedures performed are shown in Table 1. 
All proximal anastomoses were to the femoral or 
superficial femoral artery. Eight patients occluded 
either one or both of their grafts within 30 post- 
operative days and were excluded from further ana- 
lysis. In the remaining 28 vein grafts (14 patients), 
primary graft stenoses requiring PTA occurred in 15 
(54%) of the grafts, with three at the proximal ana- 
stomosis, three mid-graft and nine at either the distal 
graft or anastomosis. Mean time to developing a vein 
graft stenosis for this group of patients was 9.6 months 
(4-34 months). 
The outcome of both vein-grafted limbs, with regard 
to developing a vein graft stenosis, for the 14 patients 
studied is shown in Table 2. For the first grafted limb 
of each patient, nine (64%) developed a significant 
stenosis, and for the second grafted limb, six (43%) 
developed a significant stenosis. So for this group of 
14 patients, six patients (43%) developed significant 
bilateral vein graft stenoses, requiring PTA, in both of 
their grafted limbs. In other words, of the nine patients 
who developed a vein graft stenosis in their first limb, 
six (67%) went on to develop a vein graft stenosis in 
their contralateral grafted limb. 
For this select group of 14 patients there were five 
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diabetics, four patients with hypertension, seven 
patients with a history of ischaemic heart disease 
and 12 patients who were either current smokers or 
apparent ex-smokers., No further analysis was per- 
formed due to the small numbers involved. 
Discussion 
For the total number of patients who have undergone 
infrainguinal vein bypass in our unit (n = 326) during 
1987 to 1996, the chance of developing a vein graft 
stenosis in that graft is 0.3 (30%). Patients who have 
undergone bilateral infrainguinal bypass grafts are a 
very select group and in this published series 54% 
of vein grafts (15 vein grafted limbs) developed a
significant stenosis, which is significantly higher (p = 
0.005) than the incidence in the total patient popu- 
lation. If we believe the hypothesis that the cause of 
intimal hyperplasia is the direct result of local factors 
alone, i.e. intra-operative in trauma, then the chance 
of developing bilateral vein graft stenoses in bilateral 
grafted limbs should be independent of one another. 
Therefore, the chance of developing independent bi- 
lateral vein graft stenoses in bilateral infrainguinal 
vein grafts is the probability of developing a stenosis 
in one grafted limb {0.3} x the probability of developing 
a stenosis in a contralateral grafted limb {0.3} =0.09 
(9%). Therefore, if this hypothesis i correct, only 9% 
of those patients undergoing bilateral infrainguinal 
vein grafts hould develop bilateral vein graft stenoses. 
However, in this selected group of patients 43% de- 
veloped bilateral vein graft stenoses. This occurrence 
is obviously higher than one would expect and the 
difference between the expected findings and the ac- 
tual findings was analysed using the binomial prob- 
ability test (p =0.0008), which demonstrates that this 
finding did not occur by chance alone. Furthermore, 
if a patient developed a significant vein graft stenosis 
in the first grafted limb, the chance of developing a
significant graft stenosis in a subsequently vein-grafted 
contralateral limb was 67%. 
What is the significance of these observations? 
Moody et al. 16 investigated the effect of local intra- 
operative vein factors such as valve sites, tributaries, 
clamp-site trauma nd residual valve cusps and dem- 
onstrated that there was no correlation between these 
factors and the development of vein graft stenosis. 
Several studies have shown that systemic factors play 
a role in the development of intimal hyperplasia, 1°-15 
but intimal hyperplasia probably develops due to a 
combination ofthese systemic risk factors and intrinsic 
vein morphology, which may well be identical for both 
long saphenous veins in each individual patient. The 
present study supports these findings because it ap- 
pears that the incidence of bilateral vein graft stenoses, 
in this select group of patients, is much higher than 
one would predict if the development of vein graft 
stenosis was due to independent variables alone, i.e. 
local factors. The present study was retrospective, and 
so specific serum markers uch as fibrinogen, lipids, 
homocysteine and carboxyhaemoglobin were unable 
to be measured. 
In conclusion, it appears that patients who have 
developed a vein graft stenosis in one grafted limb 
have a greater chance than one would predict of 
developing a vein graft stenosis in the contralateral 
limb if it is subsequently vein-grafted. This further 
supports the theory that the development of vein graft 
stenosis is the result of a systemic pathological process 
and/or vein morphology intrinsic to each individual 
patient. These observations should be taken into ac- 
count when assessing patients for possible infra- 
inguinal vein grafting in the second ischaemic lower 
limb. Vascular surgeons hould also be more aware of 
this increased risk during the postoperative in graft 
surveillance of this very select group of patients. 
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